Skip to Content


Matt Richtel and Andrew Pollack, quoting Rachel E. Sachs (Academic Fellow alumna)
New York Times
December 19, 2016

Read the Full Article

From the article:

Rachel Sachs, an associate law professor at Washington University in St. Louis and expert in innovation policy, said the government had every right to seek price concessions. She noted that the government, through Medicare and Medicaid, was effectively buying its inventions back from itself. “The public is paying for the research and to the extent that many people, if not most, will pay through public insurance, we’re paying again,” she said.

Read the full piece!

Read the Full Article

Tags

biotechnology   health care finance   health law policy   innovation   medicare-medicaid   pharmaceuticals   regulation   research funding